Home › Seizures › Washington › Seattle
Seizures clinical trials in Seattle, WA
4 studies for Seizures are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
RecruitingPhase 1
- Seattle Children's Hospital, Seattle
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
RecruitingPhase 3
- Seattle Children's Hospital, Seattle
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
RecruitingPhase 3
- University of Washington Regional Epilepsy Center, Seattle
Pediatric Dose Optimization for Seizures in Emergency Medical Services
RecruitingPhase 3
- University of Washington, Seattle
About Seizures
Seizures are caused by sudden, abnormal electrical activity in the brain. They can be mild or severe. Learn about the types, causes, and treatments.
More about Seizures on MedlinePlus
Seizures trials in other cities
- Washington, DC13 studies
- New York City, NY12 studies
- Philadelphia, PA11 studies
- Houston, TX8 studies
- Boston, MA8 studies
- Birmingham, AL7 studies
- Miami, FL6 studies
- Dallas, TX6 studies
- Chicago, IL6 studies
- Durham, NC6 studies
- Cincinnati, OH6 studies
- Clifton, NJ5 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)49 studies
- Prostate Cancer42 studies
- Acute Myeloid Leukemia40 studies
- Breast Cancer39 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer30 studies
- Multiple Myeloma22 studies
- Myelodysplastic Syndromes21 studies
- Acute Lymphoblastic Leukemia21 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.